Amelioration of diabetes by imatinib mesylate (Gleevec®):: role of β-cell NF-κB activation and anti-apoptotic preconditioning

Amelioration of diabetes by imatinib mesylate (Gleevec®):: role of β-cell NF-κB activation and anti-apoptotic preconditioning
复制标题

DOI:
10.1096/fj.06-6910com
复制
发表时间:
2007-02-01
期刊:
影响因子:
4.8
通讯作者:
Welsh, Nils
Welsh, Nils
中科院分区:
生物学2区
文献类型:
--
作者:
Hagerkvist, Robert;Sandler, Stellan;Welsh, Nils

文献摘要

被引文献

相似文献

最近有报道称,酪氨酸激酶抑制剂甲磺酸伊马替尼(Gleevec(R))可能通过降低胰岛素抵抗来改善2型糖尿病。然而,由于2型和I型糖尿病的特征都是β细胞功能障碍和死亡,我们研究了伊马替尼是否通过维持β细胞功能来对抗糖尿病。我们观察到,伊马替尼抵消糖尿病在两种动物模型,链脲佐菌素注射小鼠和非肥胖糖尿病小鼠,这是由部分保存的P细胞群。此外,伊马替尼在体外暴露于NO、细胞因子和链脲佐菌素时减少了人β细胞的死亡。通过siRNA介导的c-Ab 1 mRNA敲低来模拟伊马替尼效应。伊马替尼通过促进类似于缺血预处理的状态来增强β细胞存活,如NF-κ B活化、增加NO和活性氧产生以及线粒体内膜去极化所证明的。伊马替尼在NF-κ B抑制剂存在下不抑制胰岛细胞死亡,表明NF-κ B活化是伊马替尼抗凋亡作用的必要步骤。我们的结论是,伊马替尼介导的P细胞存活,这可能有助于在糖尿病中观察到的有益效果。
It was recently reported that tyrosine kinase inhibitor imatinib mesylate (Gleevec (R)) improves Type 2 diabetes, possibly by decreasing insulin resistance. However, as both Type 2 and Type I diabetes are characterized by beta-cell dysfunction and death, we investigated whether imatinib counteracts diabetes by maintaining beta-cell function. We observed that imatinib counteracted diabetes in two animal models, the streptozotocin-injected mouse and the nonobese diabetes mouse, and that this was paralleled by a partial preservation of the P-cell mass. In addition, imatinib decreased the death of human beta-cells in vitro when exposed to NO, cytokines, and streptozotocin. The imatinib effect was mimicked by siRNA-mediated knockdown of c-Ab1 mRNA. Imatinib enhanced beta-cell survival by promoting a state similar to ischemic preconditioning, as evidenced by NF-kappa B activation, increased NO and reactive oxygen species production, and depolarization of the inner mitochondrial membrane. Imatinib did not suppress islet cell death in the presence of an NF-kappa B inhibitor, suggesting that NF-kappa B activation is a necessary step in the antiapoptotic action of imatinib. We conclude that imatinib mediates P-cell survival and that this could contribute to the beneficial effects observed in diabetes.